| 发明名称 |
Benzothiazolone compound |
| 摘要 |
The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form;
a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions. |
| 申请公布号 |
US8933108(B2) |
申请公布日期 |
2015.01.13 |
| 申请号 |
US201213603990 |
申请日期 |
2012.09.05 |
| 申请人 |
Novartis AG |
发明人 |
Cao Jun;Erb Bernhard;Fairhurst Robin Alec;Grandeury Arnaud;Hatakeyama Shinji;Koziczak-Holbro Magdalena;Lai Xinzhong;Lustenberger Philipp;Riebesehl Bernd;Tufilli Nicola;Ullrich Thomas;Wu Xiang;Zhou Jianguang |
| 分类号 |
A01N43/78;A61K31/425;C07D277/62;C07D277/68;C07D327/04;C07D343/00;C07D327/10;C07D339/02;C07D341/00;C07D409/00;C07D411/00;C07D495/00;C07D497/00;A61K31/428;A61K45/06 |
主分类号 |
A01N43/78 |
| 代理机构 |
|
代理人 |
Alexander John B. |
| 主权项 |
1. A method of treatment of muscular dystrophy, disuse-related atrophy, cachexia or sarcopenia comprising administering to a subject in need thereof a compound of formula (I) in free form or in pharmaceutically acceptable salt form which is |
| 地址 |
Basel CH |
